16/05/2022

Safety and activity of the selective FGFR 1-3 inhibitor pemigatinib

09/05/2022

Breast tumor microenvironment structures are associated with clinical outcomes

02/05/2022

A new screening platform to discover novel KRAS inhibitors

25/04/2022

A novel approach to target enhancer-addicted cancers

18/04/2022

Pro-tumorigenic mechanisms of leukaemia

11/04/2022

Pyrotinib plus capecitabine in breast cancer with brain metastases

04/04/2022

Lenvatinib and pembrolizumab efficacy in endometrial cancer

28/03/2022

Breast cancer, a mechanism to bypass anti-ER and anti-HER2 resistance

21/03/2022

MEK inhibition enhances chemoimmunotherapy